HeiQ PLC Director/PDMR Shareholding (0456C)
February 17 2022 - 9:35AM
UK Regulatory
TIDMHEIQ
RNS Number : 0456C
HeiQ PLC
17 February 2022
17 February 2022
HeiQ Plc
("HeiQ" or "the Company")
Director / PDMR Dealing
HeiQ Plc (LSE: HEIQ), a Swiss IP innovator and established
global brand in materials and textile innovation which operates in
high-growth markets, has been notified that on 16 February 2022,
Carlo Centonze, Chief Executive Officer of the Company, purchased
33,000 ordinary shares of 30 pence each in the Company ("Ordinary
Shares") at a price of 90 pence per share.
Following the purchase, Mr Centonze holds an interest in
13,887,146 Ordinary Shares, including 5,186,237 Ordinary Shares
held by Cortegrande AG, a company wholly owned by Mr Centonze. The
total interest held by Mr Centonze represents approximately 10.63
per cent. of the Company's issued ordinary share capital.
This announcement, including the notification below, is made in
accordance with the requirements of the UK Market Abuse
Regulation.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Carlo Centonze
-------------------------------- ---------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Chief Executive Officer
-------------------------------- ---------------------------------
b) Initial notification Initial Notification
/Amendment
-------------------------------- ---------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name HeiQ plc
-------------------------------- ---------------------------------
b) LEI 213800IGT65IMJDO4S03
-------------------------------- ---------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of 30p each
financial instrument,
type of instrument
GB00BN2CJ299
Identification code
-------------------------------- ---------------------------------
b) Nature of the transaction Purchase of Ordinary Shares
-------------------------------- ---------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
90.0p 33,000
----------
-------------------------------- ---------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
-------------------------------- ---------------------------------
e) Date of the transaction 16 February 2022
-------------------------------- ---------------------------------
f) Place of the transaction London Stock Exchange
-------------------------------- ---------------------------------
For further information, please contact:
HeiQ Plc
Carlo Centonze (CEO) +41 56 250 68 50
Cenkos Securities plc (Joint Broker)
Stephen Keys / Callum Davidson +44 (0) 207 397 8900
---------------------
SEC Newgate (Media Enquiries) +44 (0) 20 3757 6882
Elisabeth Cowell / Robin Tozer / Megan Kovach HeiQ@s ecnewgate
.co.uk
---------------------
About HeiQ
HeiQ is focused on improving the lives of billions of people
world-wide by innovating the materials people use every day. HeiQ
has strong IP which is at the forefront of global technology in the
$10 billion antimicrobial fabrics market, $24 billion textile
chemicals market, the $50 billion probiotics market and the $150
billion man-made fibers market. It has also moved into the medical
device, healthcare and hygiene coatings markets, to help make
hospitals and healthcare environments more hygienic. HeiQ aims to
deliver growth for its shareholders through a combination of
increased sales of its core products and by entering additional
lucrative markets through disruptive innovations and M&A.
HeiQ has created some of the most effective, durable and
high-performance technologies in the market today, which cool,
warm, dry, repel, purify, and destroy viruses. Since 2005, HeiQ has
developed over 200 technologies in partnership with 300 major
brands and it has a significant R&D pipeline containing over 50
projects. The Company has won multiple awards and gained a strong
reputation for the ESG & sustainable downstream effect of its
innovations. HeiQ is the only company to have won the Swiss
Technology award twice. It has also won the Swiss Environmental
award with an innovation that saves energy and water consumption
during the textile manufacturing process.
Led by an experienced leadership team, HeiQ researches new
solutions for partners, delivers scaled up manufacturing from its
sites across the world and helps partners market the product to end
consumers - aiming for lab to consumer in months.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFVSFFIDLIF
(END) Dow Jones Newswires
February 17, 2022 09:35 ET (14:35 GMT)
Heiq (LSE:HEIQ)
Historical Stock Chart
From Dec 2024 to Jan 2025
Heiq (LSE:HEIQ)
Historical Stock Chart
From Jan 2024 to Jan 2025
